Cargando…
Disturbing miR-182 and -381 Inhibits BRD7 Transcription and Glioma Growth by Directly Targeting LRRC4
Inactivated LRRC4 has been clinically detected in gliomas, and promoter hypermethylation has been implicated as the mechanism of inactivation in some of those tumors. Our previous researches indicated that LRRC4 is a target gene of miR-381, the interaction of miR-381 and LRRC4 is involved in glioma...
Autores principales: | Tang, Hailin, Wang, Zeyou, Liu, Qing, Liu, Xiaoping, Wu, Minghua, Li, Guiyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880275/ https://www.ncbi.nlm.nih.gov/pubmed/24404152 http://dx.doi.org/10.1371/journal.pone.0084146 |
Ejemplares similares
-
MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells
por: Liu, Xiaoping, et al.
Publicado: (2015) -
Correction: MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells
por: Liu, Xiaoping, et al.
Publicado: (2020) -
MiR-185 Targets the DNA Methyltransferases 1 and Regulates Global DNA Methylation in human glioma
por: Zhang, Zuping, et al.
Publicado: (2011) -
Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors
por: Wang, Zeyou, et al.
Publicado: (2014) -
Promoter Hypermethylation-mediated Inactivation of LRRC4 in Gliomas
por: Zhang, Zuping, et al.
Publicado: (2008)